» Articles » PMID: 18400190

Cytokine Signaling Modules in Inflammatory Responses

Overview
Journal Immunity
Publisher Cell Press
Date 2008 Apr 11
PMID 18400190
Citations 359
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokine signaling via a restricted number of Jak-Stat pathways positively and negatively regulates all cell types involved in the initiation, propagation, and resolution of inflammation. Here, we focus on Jak-Stat signaling in three major cell types involved in inflammatory responses: T cells, neutrophils, and macrophages. We summarize how the Jak-Stat pathways in these cells are negatively regulated by the Suppressor of cytokine signaling (Socs) proteins. We emphasize that common Jak-Stat-Socs signaling modules can have diverse developmental, pro- and anti-inflammatory outcomes depending on the cytokine receptor activated and which genes are accessible at a given time in a cell's life. Because multiple components of Jak-Stat-Socs pathways are mutated or closely associated with human inflammatory diseases, and cytokine-based therapies are increasingly deployed to treat inflammation, understanding cytokine signaling will continue to advance our ability to manipulate chronic and acute inflammatory diseases.

Citing Articles

Maximizing Insights, Minimizing Animal Testing: A Framework for Validating Multiparametric Single-Cell Cytokine Analysis Panels.

Aleith J, Bergmann-Ewert W, Muller-Hilke B Eur J Immunol. 2025; 55(3):e202451193.

PMID: 40071676 PMC: 11898573. DOI: 10.1002/eji.202451193.


The genetics of hyper IgE syndromes.

AlYafie R, Velayutham D, van Panhuys N, Jithesh P Front Immunol. 2025; 16:1516068.

PMID: 40040707 PMC: 11876172. DOI: 10.3389/fimmu.2025.1516068.


Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions.

Karjalainen A, Witalisz-Siepracka A, Prchal-Murphy M, Martin D, Sternberg F, Krunic M Cell Mol Life Sci. 2025; 82(1):98.

PMID: 40025196 PMC: 11872851. DOI: 10.1007/s00018-025-05625-9.


Current status and new directions for hepatocellular carcinoma diagnosis.

Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R Liver Res. 2025; 8(4):218-236.

PMID: 39958920 PMC: 11771281. DOI: 10.1016/j.livres.2024.12.001.


Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation.

Fan X, Liu S, Yu J, Hua J, Feng Y, Wang Z Drug Des Devel Ther. 2025; 19:737-757.

PMID: 39911447 PMC: 11796443. DOI: 10.2147/DDDT.S487496.


References
1.
Zhou L, Ivanov I, Spolski R, Min R, Shenderov K, Egawa T . IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007; 8(9):967-74. DOI: 10.1038/ni1488. View

2.
Boulay J, OShea J, Paul W . Molecular phylogeny within type I cytokines and their cognate receptors. Immunity. 2003; 19(2):159-63. DOI: 10.1016/s1074-7613(03)00211-5. View

3.
Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford W . Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 2007; 109(10):4368-75. PMC: 1885496. DOI: 10.1182/blood-2006-11-055756. View

4.
Watford W, OShea J . Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity. 2006; 25(5):695-7. DOI: 10.1016/j.immuni.2006.10.007. View

5.
Ma H, Liang S, Li J, Napierata L, Brown T, Benoit S . IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 2008; 118(2):597-607. PMC: 2200300. DOI: 10.1172/JCI33263. View